Form 4/A for CC Chemours Co
Accepted 2023-06-12 00:00:00 ET · period of report 2023-06-09 · accession 0001209191-23-036162 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-06-12 | 2023-06-09 | CC | Newman Mark | Pres, CEO, Dir | P - Purchase | $32.63 | +7,661 | 267.0K | +3% | +$250.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-09 | P | A | 7,661 | $32.63 | 266,954.57 | D | — | — | (F1) The original Form 4, filed on June 12, 2023, is amended by this Form 4 amendment solely to correct the price of reported stock purchased. (F2) Includes directly owned shares, restricted stock units and dividend equivalent units. |